PACIRA BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition.

On January 5, 2023, Pacira BioSciences, Inc. issued a press release announcing its preliminary unaudited revenue for the month, fourth quarter, and full-year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

       Exhibit                               Description
       Number

        99.1          Press Release dated January 5, 2023.

         104        Cover Page Interactive Data File (Formatted as Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses